Login to Your Account



Waiting on Alexion?

Complement-Blocking Strategy Against Bacterial Meningitis

By Sharon Kingman


Friday, September 23, 2011
LONDON – An antibody to a component of the complement cascade may have the potential to provide a new treatment for bacterial meningitis – if the company that manufactures it will release enough of it to allow large-scale trials to take place.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription